JP2005518187A5 - - Google Patents

Download PDF

Info

Publication number
JP2005518187A5
JP2005518187A5 JP2003526954A JP2003526954A JP2005518187A5 JP 2005518187 A5 JP2005518187 A5 JP 2005518187A5 JP 2003526954 A JP2003526954 A JP 2003526954A JP 2003526954 A JP2003526954 A JP 2003526954A JP 2005518187 A5 JP2005518187 A5 JP 2005518187A5
Authority
JP
Japan
Prior art keywords
gβγ
phosducin
contractility
compound
test compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003526954A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005518187A (ja
Filing date
Publication date
Priority claimed from US09/951,030 external-priority patent/US20030049258A1/en
Application filed filed Critical
Publication of JP2005518187A publication Critical patent/JP2005518187A/ja
Publication of JP2005518187A5 publication Critical patent/JP2005518187A5/ja
Withdrawn legal-status Critical Current

Links

JP2003526954A 2001-09-11 2002-09-11 心臓、心筋または心筋細胞の収縮能を増大する方法 Withdrawn JP2005518187A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/951,030 US20030049258A1 (en) 2001-09-11 2001-09-11 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
PCT/EP2002/010205 WO2003022882A2 (en) 2001-09-11 2002-09-11 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle

Publications (2)

Publication Number Publication Date
JP2005518187A JP2005518187A (ja) 2005-06-23
JP2005518187A5 true JP2005518187A5 (https=) 2006-01-05

Family

ID=25491176

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003526954A Withdrawn JP2005518187A (ja) 2001-09-11 2002-09-11 心臓、心筋または心筋細胞の収縮能を増大する方法

Country Status (5)

Country Link
US (1) US20030049258A1 (https=)
EP (1) EP1497425A2 (https=)
JP (1) JP2005518187A (https=)
AU (1) AU2002338665A1 (https=)
WO (1) WO2003022882A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2301564A1 (en) 2002-05-04 2011-03-30 Acorda Therapeutics, Inc. Compositions and methods for promoting neuronal outgrowth
EP1477475A1 (en) * 2003-05-16 2004-11-17 Procorde GmbH Compounds for use as a medicine increasing the contractility of a heart, a heart muscle or cells of a heart muscle
EP3514238B1 (en) * 2003-05-16 2021-05-05 Acorda Therapeutics, Inc. Proteoglycan degrading mutants for treatment of cns
US7959914B2 (en) 2003-05-16 2011-06-14 Acorda Therapeutics, Inc. Methods of reducing extravasation of inflammatory cells
US8226941B2 (en) 2004-05-18 2012-07-24 Acorda Therapeutics, Inc. Methods of purifying chondroitinase and stable formulations thereof
JP5189985B2 (ja) 2005-09-26 2013-04-24 アコーダ セラピューティクス、インク． コンドロイチナーゼａｂｃｉ変異体を用いた組成物およびその使用方法
US7722864B2 (en) 2006-10-10 2010-05-25 Acorda Therapeutics, Inc. Compositions and methods of using chondroitinase ABCI mutants
WO2019155041A1 (en) * 2018-02-12 2019-08-15 Vib Vzw Gβγ COMPLEX ANTIBODIES AND USES THEREOF
WO2024162286A1 (ja) * 2023-01-31 2024-08-08 富士フイルム株式会社 薬剤の評価方法、試薬およびキット

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040402A2 (en) * 1997-03-10 1998-09-17 Boehringer Mannheim Gmbh INHIBITORS OF G-PROTEIN-β/η SUBUNIT FUNCTION
EP0981352B8 (en) * 1997-05-07 2009-06-17 Pharma Mar, S.A. Use of aplidine for the treatment of cardiovascular diseases
AUPQ480399A0 (en) * 1999-12-22 2000-02-03 Commonwealth Scientific And Industrial Research Organisation Unsaturated fatty acids and their uses in therapy

Similar Documents

Publication Publication Date Title
Yamashita et al. Characterization of multiple members of the HSP70 family in platyfish culture cells: molecular evolution of stress protein HSP70 in vertebrates
Buckingham et al. Lipocortin 1: a second messenger of glucocorticoid action in the hypothalamo-pituitary-adrenocortical axis
Pashmforoush et al. Structure and expression of the insulin-like peptide receptor from amphioxus
CA2306448A1 (en) Models and treatments for cardiac hypertrophy in relation with nf-at3 function
KR20000053017A (ko) 사이토킨에 대한 세포 반응을 조절하는 치료 및 진단시약
WO2008063330A2 (en) Molecular control of brown fat differentiation and energy expenditure
JP2005518187A5 (https=)
JP2002508923A (ja) 心肥大において差示的に発現される遺伝子、ならびに処置および診断におけるそれらの使用
Hein et al. Receptor and binding studies
Huang et al. Transforming growth factor-β induces the expression of ANF and hypertrophic growth in cultured cardiomyoblast cells through ZAK
Ryu et al. Molecular cloning and transcript expression of genes encoding two types of lipoprotein lipase in the ovary of cutthroat trout, Oncorhynchus clarki
US7144706B2 (en) Methods of modulating localization and physiological function of IP3 receptors
Martins et al. Calcitonin receptor family evolution and fishing for function using in silico promoter analysis
WO2003073107A2 (en) Neuropeptide receptor and uses thereof
Dai et al. Characterization of a novel gene encoding zinc finger domains identified from expressed sequence tags (ESTs) of a human heart cDNA database
Papanastasiou et al. Cloning and phylogenetic analysis of the alpha subunit of the eighth complement component (C8) in rainbow trout
WO2002004491A2 (en) Methods and compositions relating to muscle selective calcineurin interacting protein (mcip)
AU2004223739A1 (en) Cyclic AMP response element activator proteins and uses related thereto
EP1758934A2 (en) Cospeptin, cosmedin and their uses
JPH1118782A (ja) 新規なヒト・ニューロテンシン・レセプター２型およびそのスプライス変種
Mishra et al. Expression of cGMP-dependent protein kinase in human atrium
US20030078376A1 (en) Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
JP2001245674A (ja) 新規ポリペプチド
CA2432278A1 (en) Methods and compositions relating to cardiac-specific nuclear regulatory factors
JP2003522522A (ja) 新規ヒトカルシウム感受性カリウムチャンネルサブユニット